Goldman sells final stake in former independent-research partner
March 15, 2013 at 19:01 PM EDT
NEW YORK, March 15 (Reuters) - Goldman Sachs Group Inc received $32.5 million for its remaining stake in Epocrates Inc, after the healthcare technology company was acquired by athenahealth Inc, according to a securities filing on Friday.
